Biovitrum to Present at the 25th Annual JPMorgan Healthcare Conference

12/21/2006 - Biovitrum’s CEO Mats Pettersson will give a corporate presentation at the 25th Annual JPMorgan Healthcare Conference being held January 8-11, 2007, at the Westin St.Francis in San Francisco, USA. The presentation is scheduled to take place on Monday January 8 at 11.00 AM (PST). A live and archived webcast will be available at https://events.jpmorgan.com.

The presentation material will be available on www.biovitrum.com under the link presentations on the investor relations page.

About Biovitrum
Biovitrum is one of the largest biopharma companies in Europe. With operations in Sweden and in the UK Biovitrum conducts research and develops pharmaceuticals for unmet medical needs both for common diseases and conditions that affect smaller patient populations. Biovitrum has a broad and balanced R&D portfolio with several projects in clinical and preclinical phases for the treatment of obesity, diabetes, inflammation and eye and blood diseases as well as a number of well defined niche indications. Biovitrum develops and produces protein-based drugs on a contractual basis and markets a range of specialist pharmaceuticals primarily in the Nordic countries. Biovitrum has revenues of approximately SEK 1.2 billion and 550 employees. Biovitrum is listed on the Stockholm Stock Exchange since September 15, 2006. For more information see www.biovitrum.com.

Contact Information

Anna Karin Källén

Vice President, Corporate Communications

Biovitrum AB

Contact via E-mail